Analysed GENPREX INC (GNPX:NASDAQ) News Sources
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
18-03-2026
yahoo.com
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
20-04-2026
yahoo.com
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
21-04-2026
yahoo.com
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
22-04-2026
yahoo.com
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
28-04-2026
yahoo.com
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
30-04-2026
yahoo.com
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
14-05-2026
yahoo.com
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
26-05-2026
yahoo.com
What is the current price of GENPREX INC (GNPX:NASDAQ)?
The current price of GENPREX INC (GNPX:NASDAQ) is $0.4844.
GENPREX INC (GNPX:NASDAQ) absolute price change since previous trading day?
The absolute price change of GENPREX INC (GNPX:NASDAQ) since the previous trading day is $0.0487.
GENPREX INC (GNPX:NASDAQ) percentage price change since previous trading day?
The percentage price change of GENPREX INC (GNPX:NASDAQ) since the previous trading day is 11.1774%.
What is the most recent average sentiment score for GENPREX INC (GNPX:NASDAQ)?
The most recent average sentiment score for GENPREX INC (GNPX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for GENPREX INC (GNPX:NASDAQ)?
The most recent sentiment for GENPREX INC (GNPX:NASDAQ) is .
SEC-8K** Filing Available For GENPREX INC (GNPX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.